ICD-10 Specific code E14: Unspecified diabetes mellitus

Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.

Translations

Language Translation
Flag for English language  English Unspecified diabetes mellitus
Flag for French language  French Diabรจte sucrรฉ, sans prรฉcision

Hierarchical position

Level Code Title
1 IV Endocrine, nutritional and metabolic diseases
2 E10-E14 Diabetes mellitus
3 E14 Unspecified diabetes mellitus

Contents

Code Title
E14.0 Unspecified diabetes mellitus: With coma
E14.1 Unspecified diabetes mellitus: With ketoacidosis
E14.2 Unspecified diabetes mellitus: With renal complications
E14.3 Unspecified diabetes mellitus: With ophthalmic complications
E14.4 Unspecified diabetes mellitus: With neurological complications
E14.5 Unspecified diabetes mellitus: With peripheral circulatory complications
E14.6 Unspecified diabetes mellitus: With other specified complications
E14.7 Unspecified diabetes mellitus: With multiple complications
E14.8 Unspecified diabetes mellitus: With unspecified complications
E14.9 Unspecified diabetes mellitus: Without complications

Indicated medicines

Active Ingredient Description
Insulin (human)

The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.

Insulin aspart

The blood glucose lowering effect of insulin aspart is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. Insulin aspart produces a more rapid onset of action compared to soluble human insulin, together with a lower glucose concentration, as assessed within the first four hours after a meal. Insulin aspart has a shorter duration of action compared to soluble human insulin after subcutaneous injection.

Insulin detemir

Insulin detemir is a soluble, long-acting insulin analogue with a prolonged duration of effect used as a basal insulin.

Insulin glargine

Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released.

Insulin glulisine

Insulin glulisine is a recombinant human insulin analogue that is equipotent to regular human insulin. Insulin glulisine has a more rapid onset of action and a shorter duration of action than regular human insulin.